Recognition of melanoma cell antigens with antibodies present in sera from patients with vitiligo

Background  Patients with vitiligo show specific losses of integumentary melanocytes, probably due to autoimmunity against melanocytes. We attempted to determine the presence of antibodies against pigment cell antigens in the sera of vitiligo patients. Methods  Detergent‐solubilized human melanoma c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of dermatology 2000-11, Vol.39 (11), p.840-843
Hauptverfasser: Rocha, Irene Machado, Oliveira, Lorena Juliana Nascimento, De Castro, Lia Cândida Miranda, De Araújo Pereira, Ledice Inácia, Chaul, Aiçar, Guerra, Jaqueline Gomes, Silvestre, Marilene Chaves, Batista, Karina Maria, Pereira, Fabiana Araújo, Gomide, Maria Abadia Consuelo, Guillo, Lidia Andreu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background  Patients with vitiligo show specific losses of integumentary melanocytes, probably due to autoimmunity against melanocytes. We attempted to determine the presence of antibodies against pigment cell antigens in the sera of vitiligo patients. Methods  Detergent‐solubilized human melanoma cells were submitted to electrophoretic separation and immunoblotted against serum samples obtained from 19 patients with vitiligo and from 20 age‐ and sex‐matched healthy individuals. Results  Eighty‐nine per cent of patients with vitiligo had antibodies to one or more pigment cell antigens. Similar antibodies were detected in 20% of healthy individuals. Antigens of 165, 90, and 68 kDa were recognized by the antibodies present in sera from 11%, 26%, and 37% of vitiligo patients, respectively, and in none of the normal sera. All patients with familial vitiligo also had antibodies to these three proteins. Conclusions  Proteins of 165, 90, and 68 kDa are specifically recognized by antibodies present in the sera of vitiligo patients and in all patients with genetic vitiligo. Whether or not these proteins might be implicated in the destruction of melanocytes by the immune system in vitiligo remains to be evaluated.
ISSN:0011-9059
1365-4632
DOI:10.1046/j.1365-4362.2000.00089.x